TickerFacts.

CVS Health Corp (CVS): Cost of Revenue

Annual figures by period end, from SEC filings.

$221.17B
Year ended 2025-12-31
$230.41B
Trailing 12 months to 2026-06-30
+4.0%
3-year compound annual growth
+6.2%
5-year compound annual growth
2016-12-31: $146.53B2017-12-31: $153.45B2018-12-31: $156.45B2019-12-31: $158.72B2020-12-31: $163.98B2021-12-31: $175.80B2022-12-31: $196.89B2023-12-31: $217.10B2024-12-31: $206.29B2025-12-31: $221.17B$221.17B
2016-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$221.17B+7.2%2026-02-10, From 2025-01-01
2024-12-31$206.29B-5.0%2026-02-10, From 2024-01-01
2023-12-31$217.10B+10.3%2026-02-10, From 2023-01-01
2022-12-31$196.89B+12.0%2025-02-12, From 2022-01-01
2021-12-31$175.80B+7.2%2024-02-07, From 2021-01-01
2020-12-31$163.98B+3.3%2023-02-08, From 2020-01-01
2019-12-31$158.72B+1.5%2022-02-09, From 2019-01-01
2018-12-31$156.45B+2.0%2021-02-16, From 2018-01-01
2017-12-31$153.45B+4.7%2020-02-18, From 2017-01-01
2016-12-31$146.53Bn/a2019-02-28, From 2016-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Retail-Drug Stores and Proprietary Stores), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
CVS Health Corp (CVS)2025-12-31$221.17B+7.2%
Guardian Pharmacy Services, Inc. (GRDN)2025-12-31$1.16B+17.5%
PetMed Express Inc (PETS)2025-03-31$157.84M-16.6%
Ridgetech Inc. (RDGT)2026-03-31$127.41M+9.7%

Compare CVS, GRDN, PETS, RDGT side by side · Screen every company in Retail-Drug Stores and Proprietary Stores ↗